SG Americas Securities LLC raised its holdings in shares of Medidata Solutions Inc (NASDAQ:MDSO) by 882.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,622 shares of the company’s stock after acquiring an additional 16,726 shares during the quarter. SG Americas Securities LLC’s holdings in Medidata Solutions were worth $1,180,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also modified their holdings of MDSO. GSA Capital Partners LLP bought a new stake in Medidata Solutions during the 2nd quarter valued at $260,000. Ark Investment Management LLC raised its holdings in Medidata Solutions by 696.2% during the 2nd quarter. Ark Investment Management LLC now owns 74,769 shares of the company’s stock valued at $5,847,000 after acquiring an additional 65,378 shares during the period. Virtu KCG Holdings LLC bought a new stake in Medidata Solutions during the 2nd quarter valued at $286,000. Dimensional Fund Advisors LP raised its holdings in Medidata Solutions by 570.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 66,589 shares of the company’s stock valued at $5,208,000 after acquiring an additional 56,653 shares during the period. Finally, Macquarie Group Ltd. raised its holdings in Medidata Solutions by 42.1% during the 2nd quarter. Macquarie Group Ltd. now owns 35,016 shares of the company’s stock valued at $2,738,000 after acquiring an additional 10,370 shares during the period. 97.52% of the stock is currently owned by institutional investors and hedge funds.
In related news, COO Michael L. Capone sold 5,000 shares of the company’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $66.33, for a total value of $331,650.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Rouven Bergmann sold 3,000 shares of the company’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $70.00, for a total transaction of $210,000.00. Following the completion of the transaction, the chief financial officer now owns 84,775 shares of the company’s stock, valued at $5,934,250. The disclosure for this sale can be found here. In the last ninety days, insiders sold 29,010 shares of company stock worth $1,962,206. Insiders own 5.80% of the company’s stock.
A number of equities research analysts have issued reports on the stock. Needham & Company LLC lowered their target price on shares of Medidata Solutions to $75.00 and set a “buy” rating on the stock in a report on Friday. Morgan Stanley lowered their target price on shares of Medidata Solutions from $86.00 to $79.00 and set an “overweight” rating on the stock in a report on Friday. Royal Bank of Canada set a $82.00 target price on shares of Medidata Solutions and gave the company a “hold” rating in a report on Thursday, February 8th. BidaskClub raised shares of Medidata Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, January 16th. Finally, Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, December 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the company’s stock. Medidata Solutions has an average rating of “Buy” and an average target price of $83.00.
Medidata Solutions Inc (MDSO) opened at $62.48 on Tuesday. The firm has a market cap of $3,807.70, a price-to-earnings ratio of 74.68, a PEG ratio of 3.49 and a beta of 1.58. Medidata Solutions Inc has a 1-year low of $54.36 and a 1-year high of $85.92. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.50 and a quick ratio of 3.37.
Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.10. The firm had revenue of $141.20 million for the quarter, compared to analysts’ expectations of $140.65 million. Medidata Solutions had a net margin of 8.14% and a return on equity of 11.59%. The business’s quarterly revenue was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.33 earnings per share. research analysts expect that Medidata Solutions Inc will post 0.9 EPS for the current year.
TRADEMARK VIOLATION WARNING: “SG Americas Securities LLC Has $1.18 Million Holdings in Medidata Solutions Inc (MDSO)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/13/sg-americas-securities-llc-has-1-18-million-holdings-in-medidata-solutions-inc-mdso.html.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.